Thyroid disorders are common endocrine conditions affecting millions of individuals globally. They are particularly prevalent in adults, with a higher incidence in women. Understanding the intricacies of these disorders is vital for healthcare professionals to provide optimal care.
The thyroid gland, located in the neck, produces hormones T3 (triiodothyronine) and T4 (thyroxine), which regulate metabolism, growth, and development. The hypothalamus and pituitary gland control thyroid hormone production and release via a feedback mechanism involving Thyroid Stimulating Hormone (TSH).
Thyroid diseases can be broadly classified into conditions causing abnormal thyroid hormone production - hypothyroidism (low levels) and hyperthyroidism (high levels), and structural abnormalities such as goiter and thyroid nodules. Autoimmune conditions like Hashimoto's thyroiditis and Graves' disease are common etiologies of hypo- and hyperthyroidism respectively.
Patients with hypothyroidism often present with fatigue, weight gain, cold intolerance, and depression, while hyperthyroidism symptoms include weight loss, heat intolerance, palpitations, and anxiety. The diagnosis involves assessment of TSH, T3, and T4 levels. Additional tests like thyroid antibodies and imaging may be required in certain cases.
Hypothyroidism is typically managed with levothyroxine replacement therapy. Hyperthyroidism treatment options include antithyroid drugs, radioactive iodine therapy, or thyroidectomy. The choice of treatment depends on the underlying cause, severity of symptoms, and patient preferences.
Thyroid disorders in adults are a significant health concern requiring a comprehensive understanding of their pathophysiology, clinical presentation, diagnosis, and management. As healthcare professionals, staying abreast with the latest advancements in this field can significantly enhance patient care.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation